• OPEN AN ACCOUNT
Indian Indices
Nifty
25,082.30 -67.55
(-0.27%)
Sensex
82,553.23 299.77
( 0.36%)
Bank Nifty
56,765.35 10.65
( 0.02%)
Nifty IT
37,273.70 -419.55
( -1.11%)
Global Indices
Nasdaq
44,472.11 79.59
(0.18%)
Dow Jones
6,289.33 8.58
(0.14%)
Hang Seng
39,646.81 187.19
(0.47%)
Nikkei 225
8,998.06 56.94
(0.64%)
Forex
USD-INR
85.82 0.14
(0.17%)
EUR-INR
100.30 -0.06
(-0.06%)
GBP-INR
115.75 -0.66
(-0.57%)
JPY-INR
0.58 0.00
(-0.62%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
101.444166
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
94.39
403580.14
EPS(TTM)
Face Value()
Div & Yield %
17.82
1
0.95
 

tahmar enterprises ltd
Cistro Telelink reports standalone net loss of Rs 0.01 crore in the March 2025 quarter
Apr 22,2025
Net Loss of Cistro Telelink reported to Rs 0.01 crore in the quarter ended March 2025 as against net loss of Rs 1.45 crore during the previous quarter ended March 2024. Sales declined 60.00% to Rs 0.02 crore in the quarter ended March 2025 as against Rs 0.05 crore during the previous quarter ended March 2024.

For the full year,net loss reported to Rs 0.16 crore in the year ended March 2025 as against net loss of Rs 1.43 crore during the previous year ended March 2024. Sales declined 45.83% to Rs 0.13 crore in the year ended March 2025 as against Rs 0.24 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales0.020.05 -60 0.130.24 -46
OPM %-50.00-40.00 --161.54-29.17 -
PBDT-0.010 0 -0.160.02 PL
PBT-0.010 0 -0.160.02 PL
NP-0.01-1.45 99 -0.16-1.43 89